Persistence of fetal vasculature in a patient with Knobloch syndrome: Potential role for endostatin in fetal vascular remodeling of the eye

Ophthalmology

Volumn 111, Issue 10, 2004, Pages 1885-1888

  Duh, Elia J ^a   Yao, Yong Gang ^a   Dagli, Manesh ^a   Goldberg, Morton F ^a,b  

^a JOHNS HOPKINS UNIVERSITY   (United States)

^b Woods 276 ^*  (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ENDOSTATIN;

ARTICLE; CASE REPORT; ECHOGRAPHY; ENZYME LINKED IMMUNOSORBENT ASSAY; EYE FUNDUS; EYE MALFORMATION; GENE MUTATION; GENOTYPE; HUMAN; KERATOPATHY; KNOBLOCH SYNDROME; MALE; MYOPIA; PRESCHOOL CHILD; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; REFRACTION ERROR; RETINA DETACHMENT; RETINOSCOPY; SLIT LAMP; VASCULARIZATION; VISUAL SYSTEM EXAMINATION; VITREOUS BODY DETACHMENT;

CEREBELLUM; CHILD; CHOROID DISEASES; COLLAGEN TYPE XVIII; DNA MUTATIONAL ANALYSIS; ENCEPHALOCELE; ENDOSTATINS; ENZYME-LINKED IMMUNOSORBENT ASSAY; EYE DISEASES, HEREDITARY; FLUORESCEIN ANGIOGRAPHY; HUMANS; HYPERPLASIA; MALE; MUTATION; MYOPIA; RETINAL DISEASES; SYNDROME; VITREOUS BODY;

EID: 4744361549     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2004.03.030     Document Type: Article

References (16)

1. Knobloch W.H., Layer J.M. Retinal detachment and encephalocele. J Pediatr Ophthalmol. 8:1971;181-184
2. Sertie A.L., Sossi V., Camargo A.A., et al. Collagen XVIII, containing an endogenous inhibitor of angiogenesis and tumor growth, plays a critical role in the maintenance of retinal structure and in neural tube closure (Knobloch syndrome). Hum Mol Genet. 9:2000;2051-2058
3. Suzuki O.T., Sertie A.L., Der Kaloustian V.M., et al. Molecular analysis of collagen XVIII reveals novel mutations, presence of a third isoform, and possible genetic heterogeneity in Knobloch syndrome. Am J Hum Genet. 71:2002;1320-1329
4. Menzel O., Bekkeheien R.C., Reymond A., et al. Knobloch syndrome novel mutations in COL18A1, evidence for genetic heterogeneity, and a functionally impaired polymorphism in endostatin. Hum Mutat. 23:2004;77-84
5. Sasaki T., Fukai N., Mann K., et al. Structure, function and tissue forms of the C-terminal globular domain of collagen XVIII containing the angiogenesis inhibitor endostatin. EMBO J. 17:1998;4249-4256
6. O'Reilly M.S., Boehm T., Shing Y., et al. Endostatin an endogenous inhibitor of angiogenesis and tumor growth. Cell. 88:1997;277-285
7. Fukai N., Eklund L., Marneros A.G., et al. Lack of collagen XVIII/endostatin results in eye abnormalities. EMBO J. 21:2002;1535-1544
8. Goldberg M.F. Persistent fetal vasculature (PFV) an integrated interpretation of signs and symptoms associated with persistent hyperplastic primary vitreous (PHPV). LIV Edward Jackson Memorial Lecture. Am J Ophthalmol. 124:1997;587-626
9. Reese A.B., Payne F. Persistence and hyperplasia of the primary vitreous (tunica vasculosa lentis or retrolental fibroplasia). Am J Ophthalmol. 29:1946;1-24
10. Reese A.B. Persistent hyperplastic primary vitreous. The Jackson Memorial Lecture. Am J Ophthalmol. 40:1955;317-331
11. Elamaa H., Snellman A., Rehn M., et al. Characterization of the human type XVIII collagen gene and proteolytic processing and tissue location of the variant containing a frizzled motif. Matrix Biol. 22:2003;427-442
12. Zorick T.S., Mustacchi Z., Bando S.Y., et al. High serum endostatin levels in Down syndrome: implications for improved treatment and prevention of solid tumours. Eur J Hum Genet. 9:2001;811-814
13. Goldberg M.F., Custis P.H. Retinal and other manifestations of incontinentia pigmenti (Bloch-Sulzberger syndrome). Ophthalmology. 100:1993;1645-1654
14. Fard A.K., Goldberg M.F. Persistence of fetal vasculature in the eyes of patients with incontinentia pigment. Arch Ophthalmol. 116:1998;682-684
15. Chang-Godinich A., Paysse E.A., Coats D.K., Holz E.R. Familial exudative vitreoretinopathy mimicking persistent hyperplastic primary vitreous. Am J Ophthalmol. 127:1999;469-471
16. Parsa C.F., Silva E.D., Sundin O.H., et al. Redefining papillorenal syndrome an underdiagnosed cause of ocular and renal morbidity. Ophthalmology. 108:2001;738-749